| B02BD02 |
Human coagulation factor VIII |
Fanhdi |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Instituto Grifols, S.A., Испания |
500 |
IU |
765.65 |
308.70999 |
617.42 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 255/ 04.11.2011; протокол №16/04.07.2013.; НСР-15711/25.05.2018 |
02.07.2018 |
08.09.2012 |
Активен |
904 |
| B02BD02 |
Human coagulation factor VIII |
Fanhdi |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Instituto Grifols, S.A., Испания |
500 |
IU |
197.88 |
308.70999 |
154.36 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 255/ 04.11.2011; протокол №16/04.07.2013.; НСР-15747/25.05.2018 |
02.07.2018 |
08.09.2012 |
Активен |
902 |
| B02BD02 |
Human coagulation factor VIII |
Haemoctin |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Biotest Pharma GmbH, Германия |
500 |
IU |
808.64 |
308.70999 |
617.42 |
100% |
|
Съгласно РУ |
КЦРР-819/15.06.2012 г.; HCР-263/28.06.2013; НСР-5168/27.11.2014 |
16.12.2014 |
08.09.2012 |
Заличен |
1924 |
| B02BD02 |
Human coagulation factor VIII |
Haemoctin |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Biotest Pharma GmbH, Германия |
500 |
IU |
410.33 |
308.70999 |
308.71 |
100% |
|
Съгласно РУ |
КЦРР-819/15.06.2012 г.; HCР-264/28.06.2013; НСР-5167/27.11.2014 |
16.12.2014 |
08.09.2012 |
Заличен |
1923 |
| B02BD02 |
Human coagulation factor VIII |
Haemoctin |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Biotest Pharma GmbH, Германия |
500 |
IU |
197.88 |
308.70999 |
154.36 |
100% |
|
Съгласно РУ |
КЦРР-819/15.06.2012 г.; HCР-267/28.06.2013; НСР-5166/27.11.2014 |
16.12.2014 |
08.09.2012 |
Заличен |
1922 |
| B02BD02 |
Human coagulation factor VIII |
Immunate |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Baxalta Innovations GmbH, Австрия |
500 |
IU |
308.71 |
308.70999 |
308.71 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 125/ 13.12.2010; НСР-2199/20.12.2013; КЦРР-213/27.02.2012 г. |
02.09.2014 |
08.09.2012 |
Активен |
2441 |
| B02BD02 |
Human coagulation factor VIII |
Immunate |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Baxter AG, Австрия |
500 |
U |
154.37 |
308.70999 |
154.36 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 125/ 13.12.2010; НСР-2201/20.12.2013; КЦРР-213/27.02.2012 г.; НСР-5427/16.01.2015 |
16.02.2015 |
08.09.2012 |
Заличен |
2440 |
| B02BD02 |
Human coagulation factor VIII |
Immunate |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Baxter AG, Австрия |
500 |
U |
605.68 |
297.5 |
595 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 125/ 13.12.2010; КЦРР-2065/24.01.2013 г; НСР-1162/13.09.2013 |
20.02.2013 |
08.09.2012 |
Заличен |
1581 |
| B02BD02 |
Human coagulation factor VIII |
Koate DVI 1000 IU powd. Inf. Vial 1000 IU + solv. Vial 10 ml |
Powder and solvent for solution for infusion |
1000 |
IU |
1 |
Химимпорт Фарма АД, България |
500 |
IU |
595 |
297.5 |
595 |
100% |
|
Съгласно РУ |
НСР-4003/30.06.2014 |
02.08.2014 |
08.09.2012 |
Заличен |
367 |
| B02BD02 |
Human coagulation factor VIII |
Koate DVI 250 IU |
Powder and solvent for solution for infusion |
250 |
IU |
1 |
Химимпорт Фарма АД, България |
500 |
IU |
151.58 |
297.5 |
148.75 |
100% |
|
Съгласно РУ |
НСР-4002/30.06.2014 |
02.08.2014 |
08.09.2012 |
Заличен |
365 |
| B02BD02 |
Human coagulation factor VIII |
Koate DVI 500 IU |
Powder and solvent for solution for infusion |
500 |
IU |
1 |
Химимпорт Фарма АД, България |
500 |
IU |
303.16 |
303.16 |
303.16 |
100% |
|
Съгласно РУ |
НСР-4206/30.07.2014 |
02.09.2014 |
08.09.2012 |
Заличен |
366 |
| B02BD02 |
Human coagulation factor VIII |
OCTANATE |
Powder and solvent for solution for injection |
500 |
IU |
1 vial powder, 1 vial solvent 10 ml, 1 syringe, 1 transfer set |
Octapharma (IP) SPRL, Белгия |
500 |
IU |
327.95 |
308.70999 |
308.71 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; НСР-12079/21.03.2017 и КП-35/29.05.2017; НСР-13385/27.07.2017 (предварително изпълнение); НСР-17616/20.12.2018 |
02.02.2019 |
08.09.2012 |
Активен |
773 |
| B02BD02 |
Human coagulation factor VIII |
OCTANATE |
Powder and solvent for solution for injection |
1000 |
IU |
1 vial powder, 1 vial solvent 10 ml, 1 syringe, 1 transfer set |
Octapharma (IP) SPRL, Белгия |
500 |
IU |
650 |
308.70999 |
617.42 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; КП-35/05.03.2015 и НСР-3051/21.03.2014.; НСР-13032/23.06.2017 предварително изпълнение,КП-36/29.05.2017 и НСР-12079/21.03.2017; НСР-17618/20.12.2018 |
02.02.2019 |
08.09.2012 |
Активен |
3650 |
| B02BD02 |
Recombinant Coagulation factor VIII (Octocog alfa, Moroctocog alfa, Turoctocog Alfa,Simoctocog Alfa) |
B02BD02 Recombinant Coagulation factor VIII (Octocog alfa, Moroctocog alfa, Turoctocog Alfa,Simoctocog Alfa) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Advate |
Powder and solvent for solution for injection |
500 |
IU |
1 vial powder + 1 vial solvent (2ml) + reconstitution device |
Baxter AG, Австрия |
500 |
IU |
726.17 |
613.54 |
613.54 |
100% |
|
Съгласно РУ |
НСР-6389/03.06.2015.; НСР-13454/11.08.2017; НСР-16871/28.09.2018 |
02.11.2018 |
|
Активен |
4000 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Advate 1000 IU |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Baxter AG, Австрия |
500 |
IU |
1349.65 |
674.82501 |
1349.65 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; КЦРР-259/06.03.2012; НСР-2214/20.12.2013; НСР-5026/17.11.2014 |
16.12.2014 |
08.09.2012 |
Заличен |
2444 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Advate 1500 IU |
Powder and solvent for solution for injection |
1500 |
IU |
1 |
Baxter AG, Австрия |
500 |
IU |
2124.08 |
684.25 |
2052.75 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; КЦРР-2634/20.03.2013 г.; НСР-1113/04.09.2013 |
02.10.2013 |
08.09.2012 |
Заличен |
1843 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Advate 250 IU |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Baxter AG, Австрия |
500 |
IU |
371.06 |
684.25 |
342.13 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; КЦРР-2635/20.03.2013 г.; НСР-1113/04.09.2013 |
02.10.2013 |
08.09.2012 |
Заличен |
1842 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Advate 500 IU |
Powder and solvent for solution for injection |
500 |
IU |
1 vial powder + 1 vial solvent (5 ml) + reconstitution device |
Baxter AG, Австрия |
500 |
IU |
684.58 |
613.54 |
613.54 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; КЦРР-259/06.03.2012; НСР-2214/20.12.2013; НСР-15430/19.04.2018 |
02.06.2018 |
08.09.2012 |
Активен |
2443 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
KOGENATE BAYER |
Powder and solvent for solution for injection |
500 IU |
|
1 vial + 1 pre-filled syringe + 1 syringe plunger rod + 1 vial adapter +1 venipuncture set + 4 swabs + 2 plasters |
Bayer AG, Германия |
500 |
IU |
676.96 |
613.54 |
613.54 |
100% |
|
Съгласно РУ |
№ 20/15,07,2009 г.; КЦРР-259/06.03.2012; КЦРР-2952/20.03.2013 г.; НСР-3235/14.04.2014; НСР-3267/14.04.2014; НСР-9627/23.06.2016 г.; НСР-14026/02.10.2017; НСР-17328/22.11.2018; НСР-21466/19.05.2020 |
02.07.2020 |
08.09.2012 |
Заличен |
2758 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
KOGENATE BAYER |
Powder and solvent for solution for injection |
500 IU |
|
1 vial + 1 Bio-Set device + 1 pre-filled syringe + 1 syringe plunger rod + 1 venipuncture set + 4 swabs + 2 plasters |
Bayer AG, Германия |
500 |
IU |
676.96 |
613.54 |
613.54 |
100% |
|
Съгласно РУ |
КЦРР-2951/20.03.2013 г.; НСР-3235/14.04.2014; НСР-3267/14.04.2014; НСР-9628/23.06.2016 г.; НСР-14025/02.10.2017; НСР-17326/22.11.2018; НСР-21472/19.05.2020 |
02.07.2020 |
08.09.2012 |
Заличен |
2757 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
KOGENATE BAYER |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Bayer Pharma AG, Германия |
500 |
IU |
356.06 |
674.82501 |
337.41 |
100% |
|
Съгласно РУ |
КЦРР-1871/15.12.2012 г; НСР-1277/25.09.2013; НСР-3803/16.06.2014. |
16.07.2014 |
|
Заличен |
2147 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Kovaltry |
Powder and solvent for solution for injection |
500 |
IU |
1 vial+1 pre-filled syringe (3 ml)+ 1 vial adapter+1 venipuncture set |
Bayer AG, Германия |
500 |
IU |
681.36 |
613.54 |
613.54 |
100% |
|
Съгласно РУ |
НСР-12791/19.05.2017(допуска предварително изпълнение); НСР-16017/29.06.2018 |
02.08.2018 |
|
Активен |
15689 |
| B02BD02 |
Coagulation Factor VIII (Turoctocog Alfa) |
NovoEight |
Powder and solvent for solution for injection |
500 |
IU |
1 vial + 1 pre- filled syringe + 1 vial adapter |
Novo Nordisk A/S, Дания |
500 |
IU |
699.46 |
613.54 |
613.54 |
100% |
|
Съгласно РУ |
НСР-6701/16.07.2015.; НСР-9206/05.05.2016; НСР-13337/28.07.2017; НСР-16869/28.09.2018 |
02.11.2018 |
|
Активен |
4038 |
| B02BD02 |
Coagulation Factor VIII (Simoctocog Alfa) |
Nuwiq |
Powder and solvent for solution for injection |
500 |
IU |
1 vial (powder) + 1 pre-filled syringe (solvent) + 1 vial adapter |
Octapharma AB, Elersvägen 40, 112 75 Stockholm, Швеция, Швеция |
500 |
IU |
699.5 |
613.54 |
613.54 |
100% |
|
Съгласно РУ |
НСР-7214/09.10.2015; НСР-11213/15.12.2016; НСР-15136/02.03.2018; НСР-18692/20.05.2019 |
02.07.2019 |
|
Активен |
4082 |